ARCHIVES

AACI Backs Year 200 Goals, Secures Pledge From NCI that New Centers Won’t Be Added At Expense of Old

This article is from The Cancer Letter archive.

Vol. 10 No. 29 | July 20, 1984

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups

November 6, 1998

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

NCI To Recompete Smokeless Tobaccos RFA as PA

January 24, 1986